MAD1L1 antibody
Quick Overview for MAD1L1 antibody (ABIN7468571)
Target
See all MAD1L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse, Potoroo, Rat
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human MAD1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: Molt-4 , Neuro2A , GL261 , C8D30 , NIH-3T3 , BCL-1 , Raw264.7 , PC-12 , Rat2 , 293T , A431 , HeLa , HepG2 Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Alternative Name
- mitotic arrest deficient 1 like 1
-
Background
-
Synonyms: mitotic arrest deficient 1 like 1 , MAD1 , PIG9 , TP53I9 , TXBP181
Background: MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq]
-
Molecular Weight
- 83 kDa
-
Gene ID
- 8379
-
UniProt
- Q9Y6D9
-
Pathways
- M Phase
Target
-